 |
인쇄하기
취소
|
4 human placenta supplies to be withdrawn from market
Four injectable preparations of human placenta extract will be excluded from the market due to the least efficacy, it was announced on March 26.
According to the announcement of the Korea Food and Drug Administration, the efficacy-lacking injections subject to market withdrawal included the ones manufactured by Green Cross Corporation, Unimed and Jinyang Pharm.
The KFDA said it will order...
According to the announcement of the Korea Food and Drug Administration, the efficacy-lacking injections subject to market withdrawal included the ones manufactured by Green Cross Corporation, Unimed and Jinyang Pharm.
The KFDA said it will order...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.